PATENT CLAIM ANALYSIS

Application Number: 15866154
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "142100"]

Abstract:
The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.

Claim (Index 7):
The composition of  claim 6 , wherein the stabilizer is combination of EDTA and one or more of glycine, alanine, glutamate, arginine, and methionine.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.36364
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15360678', '14661899', '14661849', '14661288', '15729295']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.803243605534435
- 35 USC 102 Novelty (BERT): 0.6506070583491228
- Combined Prediction Score: 0.7879799508159038
- Mean Citation Score: 563.6813519999997
- Max Citation Score: 584.3809
- Similarity Product: 575.3749249931574

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test